Caza Gold Shareholders Approve All Resolutions at AGM

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Caza Gold Shareholders Approve All Resolutions at AGM

VANCOUVER, CANADA--(Marketwired - June 20, 2013) - Greg Myers, CEO and President of Caza Gold Corp. (TSX VENTURE:CZY)(FRANKFURT:CZ6)(OTCQX:CZGDF), is pleased to announce that the Company completed its Annual General Meeting on June 12, 2013 and all resolutions at the AGM were approved.

Messrs. Bradford Cooke, Greg Myers, Anthony Hawkshaw, Stewart Lockwood, and Philip Yee were re-elected to the Board of Directors for the ensuing year. The Board of Directors re-appointed Dr. Greg Myers as CEO, Mr. Marco Montecinos as Vice-President of Exploration and Mr. Philip Yee as CFO and Vice-President of Finance.

Shareholders voted in favor of the implementation of an Advance Notice Policy for the nomination of Directors. In addition, shareholders voted in favor to appoint Smythe Ratcliffe LLP as auditors. The Company's rolling stock option plan was also approved.

Caza Gold Corp. is a gold and copper exploration company focused on the acquisition and exploration of strategic properties in Nicaragua and Mexico. The Company is an experienced mineral exploration company that is one of the largest landholders in the highly prospective, yet largely undeveloped, country of Nicaragua, with additional properties in the mining rich country of Mexico. Caza Gold Corp is dedicated to discovering gold, defining deposits, and developing value.

CAZA GOLD CORP.

Per:

Greg Myers, PhD, P. Geo, President and CEO

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

CAUTIONARY DISCLAIMER - FORWARD-LOOKING STATEMENTS

This news release includes certain statements and information that may contain forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, the likelihood of commercial mining and financing requirements and the ability to fund future exploration and development are forward-looking statements and contain forward-looking information. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbour.

Caza Gold Corp. Terry Johnston (604) 267-3007 or Toll Free: 1 (855) 685-9750 (604) 685-9744 (FAX) terry@cazagold.com www.cazagold.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 1

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 8

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Equity Alerts: Unraveling the Latest M&A Surprises

Updated Category News Views 5

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Continue Reading
ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

Updated Category News Views 9

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
MOOV Emerges as a Strong AI Contender in Canada

Updated Category News Views 2

A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...

Continue Reading
Compounded Meds: A Tailored Approach to Health Needs

Updated Category News Views 1

Custom Compounding: A Lifeline for Specific Needs Standard meds can sometimes feel like a one-size-fits-all shirt—sure it fits, but not comfortably for everyone. Enter the world of custom-compounded medications, where pharmacists like Laura Temple in Azle, Texas, create tailor-made solutions for patients. Think of it as fine-tuning the exact gear needed to climb that...

Continue Reading
WuXi Biologics Clinches Top ESG Honors in Award Circuit

Updated Category News Views 5

Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 6

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights

Updated Category News Views 4

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Continue Reading

Top 5 Most Recently Viewed Articles

Definitive Healthcare Celebrated as a Top Boston Employer

Updated Category News Views 89

Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....

Continue Reading
Euroseas Q4 Earnings Beat Expectations: Key Insights

Updated Category News Views 157

Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...

Continue Reading
AstraZeneca and Daiichi Sankyo's Datroway: A Game Changer

Updated Category News Views 208

Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...

Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics

Updated Category News Views 806

Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...

Continue Reading
NuZee Stock Surges on Major Operational Changes and Leadership Shift

Updated Category News Views 88

NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...

Continue Reading